Salisbury Foundation Trust

FOI_4689

Internal Reference Number: FOI_4689

Date Request Received: 31/10/2018 15:05:29

Date Request Replied To: 04/12/2018 11:16:26

This response was sent via: By Email

Request Summary: Moderate / severe atopic dermatitis

Request Category: Private Individuals

 
Question Number 1:
How many patients are currently (within the last 3 months) being treated for moderate or severe atopic dermatitis (also known as eczema) ?
 
Answer To Question 1:
81
 
Question Number 2:
Of these treated patients how many are paediatric?


Drug Name : Total

Acitretin:
Alitretinoin:
Pimecrolimus:
Tacrolimus:
Dupixent (Dupilumab):
Phototherapy including with ultraviolet (UVB) radiation or psoralen ultraviolet A (PUVA):

Potent Topical Corticosteroids (creams or ointments) total

Amcinonide 0.05% (Cyclocort):
Betamethasone diproprionate 0.05% (Diprosone):
Betamethasone valerate:
Clobetasol proionate:
Desoximetasone 0.25% (Topicort):
Diflucortolone valerate:
Fluocinonide 0.05% (Lidex):
Fluticasone proprionate 0.005% (Cutivate):
Halcinonide 0.05% (Halog):
Mometasone furoate 0.1% (Elocon ointment):
Triamcinalone acetonide 0.5% (Kenalog, Aristocrt cream) :
Betamethasone dipropionate 0.25% (Diprolene):
Clobetasol dipropionate 0.05% (Temovate):
Diflorasone diacetate 0.05% (Psorcon):
Halbetasol proprionate 0.05% (Ultravate):

Immunosppressive therapies total

Azathioprine:
Ciclosporin:
Methotrexate:
 
Answer To Question 2:
31 patients out of the 81 identified are Paediatric.

Drug Name : Total

Acitretin:
Alitretinoin:
Pimecrolimus:
Tacrolimus:
Dupixent (Dupilumab):
Phototherapy including with ultraviolet (UVB) radiation or psoralen ultraviolet A (PUVA): 6

Potent Topical Corticosteroids (creams or ointments) total

Amcinonide 0.05% (Cyclocort):
Betamethasone diproprionate 0.05% (Diprosone):
Betamethasone valerate: 11
Clobetasol proionate: 10
Desoximetasone 0.25% (Topicort):
Diflucortolone valerate: 1
Fluocinonide 0.05% (Lidex):
Fluticasone proprionate 0.005% (Cutivate):
Halcinonide 0.05% (Halog):
Mometasone furoate 0.1% (Elocon ointment): 32
Triamcinalone acetonide 0.5% (Kenalog, Aristocrt cream) :
Betamethasone dipropionate 0.25% (Diprolene):
Clobetasol dipropionate 0.05% (Temovate):
Diflorasone diacetate 0.05% (Psorcon):
Halbetasol proprionate 0.05% (Ultravate):

Immunosppressive therapies total: 0

Azathioprine:
Ciclosporin:
Methotrexate:
 
Question Number 3:
Does your Trust use any of the following to treat severe dermatitis ? If so how many patients in the past 3 months ?

Drug Name: Total

Etanercept:
Infliximab:
Adalimumab:
Ustekinumab:

 
Answer To Question 3:
No - zero
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values